Sumitomo Bakelite Co., Ltd. [Shinagawa-ku, Tokyo, President: Kazuhiko Fujiwara] and Sumitomo Dainippon Pharma Co., Ltd. [Osaka-shi, Osaka, Representative Director, President and CEO: Hiroshi Nomura] hereby announce the establishment of a new joint company, SB Bioscience Co., Ltd., on 9th October 2018. SB Bioscience Co., Ltd. will take over the business of in-vitro diagnostics business that is currently operated by DS Pharma Biomedical Co., Ltd. [Suita-shi, Osaka, Representative Director, President: Susumu Nakajima], which is wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd.. The preparation for business succession is being proceeded and the new company is planning to commence its business on April 1st, 2019.

Sumitomo Bakelite Co., Ltd. has been providing products and services for Quality of Life area as one of the main business segments. As a part of the activities, Bio related business including plastic cell culture labware, glycan analysis kit, and microfluidics articles has been actively enhanced. Through DS Pharma Biomedical Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd. also has been providing the products and services of in-vitro diagnostics for infectious disease, bone/calcium metabolism, cardiovascular diseases, and others.

By combining the know-how of in-vitro diagnostics of DS Pharma Biomedical Co., Ltd. and the technologies of Sumitomo Bakelite Co., Ltd., we believe that we can accelerate new diagnostics development and make a further contribution to the society.

Sumitomo Bakelite Co., Ltd. will strengthen our technologies with better understanding of the in-vitro diagnostics area and continue the business supplying for other diagnostics companies.

Announcement of the establishment of new joint company
by Sumitomo Bakelite Co., Ltd. and Sumitomo Dainippon Pharma Co., Ltd.（PDF 122KB）

Corporate Communications Dept.
Corporate General Affairs Div.
Sumitomo Bakelite Co., Ltd.
TEL: +81-3-5462-4818

Public & Investor Relations Group, Corporate Governance
Sumitomo Dainippon Pharma Co., Ltd.
TEL: +81-6-6203-1407 (Osaka); +81-3-5159-3300 (Tokyo)

Corporate Planning & Administration
DS Pharma Biomedical Co., Ltd.
TEL: +81-6-6337-5940